Since the advent of Manufacturing Execution Systems (MES, or MOM for those who prefer) in the late 1980s, life sciences, and especially pharmaceuticals finishing and packing, led the way in useful MES solutions. Some would argue that MES for pharma has reached maturity and there are few gains to be made. At LNS Research, we believe that change is just beginning and it is time for the pharma software industry to wake up or get severely disrupted by new players.

Many pharmaceutical companies, ranging from boutique startups to the global giants, have active Industrial Transformation (IX) programs that foresee structural changes in the way they operate. Existing pharma MES systems provide the necessary functionality for most operations but are hard to maintain, inflexible, and do not provide a data platform for other parts of the enterprise. Such integration will, inevitably, be a part of IX programs. 

Seventh Life of MOM - Refined

Almost four years ago, I wrote about the "7 lives of MOM," a vision into the future of MOM architecture, and how it would be deployed. The 7^th life was defined as “No MOM,” where the functionality previously implemented in MOM systems would be distributed as apps across an Industrial IOT (IIoT) platform. This still seems like a good idea to most and the reality is getting closer, but in a different environment than that we had envisioned.

Manufacturing Operations Management (MOM or MES) systems have been commonly implemented in batch and discrete manufacturing plants for many years (Early MES was implemented in the 1980s). The benefits to automation, control, and business are well understood but the number of manufacturers implementing MOM has remained constant in our surveys over the last years at around 20% of factories. There is a multitude of reasons, often focused on the gap between expectations and reality; for example a company might implement one factory and then judge the cost and time of rolling out 20 more completely prohibitive. We have consistently been promised more for less and yet we are still being led down the same path. Things are changing; in this blog we will look at some of the trends that are going to help manufacturers overcome these challenges in the coming year or two.

LNS recently participated in Plex Systems’ annual customer event, PowerPlex 2020, which was held virtually for the first time.  Three themes emerged from the event. 

In our Industrial Transformation (IX) Readiness work, there are many surprising results from the research. Two of the most surprising are:

It should be “event season” except, as my daughter says, “everything is cancelled.”  Vendors have three choices in this era of Social Distancing: cancel their event, postpone their event, or go virtual. iBASEt has gone the “postpone” route with a goal of having their customer conference Excelerate 2020 in the fall.  In the meantime, they briefed LNS Research on their progress.

IIoT has become a primary talking point about not only Industry 4.0 (I4.0), but all of the other digitalization topics around I4.0 such as analytics, artificial intelligence, augmented reality/virtual reality and digital twins. The ability to get information from the factory floor and move it anywhere and to anyone cheaply and in real time has driven IIoT into virtually every manufacturer and asset intensive industry client and vendor community discussion lately. With so much focus, both from management and leadership and technical and engineering staff, why then, have so few industrial internet of things (IIoT) projects moved out of pilot purgatory and into full scale production. Some will argue the business case isn’t there yet, others will argue that the technology is not ready or scalable yet while others say something else is lacking like leadership support or adequate deployment and support skills. There is possibly an even more fundamental cause projects are stalling; cultural wars inside the organization are inhibiting progress.

Technology has almost always proven most beneficial when it operates within an ecosystem. The adage “the whole is greater than the sum of the parts” is especially true in the world of technology. Smartphones have changed the world because they operate within multiple technological ecosystems. If they did not allow phone calls to landlines or to subscribers of other providers, they would be of limited use. Without GPS much of the smartphones value would gone. Bluetooth makes lining the smartphone to other devices easy and provides not only wireless headsets but connectivity to vehicles and other devices. What makes all of this connectivity work? Standards. The same holds true in the industrial automation sector.

Over the last decade, Siemens has gone through a massive transformation, not least in its software businesses. The current home for its comprehensive offerings is the Digital Industries Software (“Siemens”) division (a part of Digital Industries that includes discrete and process controls, automation, and drives). Siemens recently held its annual conference for media and analysts in New York where it brought us up to date on its impressive progress in software solutions. Announcements primarily related to how the company is bringing different parts of the portfolio together. We don’t perceive that as a lack of progress, but rather a demonstration of ever more sophisticated solutions around the Digital Twin.

LNS Research was delighted to be invited again to Dassault Systèmes’ (3DS) annual get together for a small band of diverse industry analysts that cover a wide range of 3DS’ industries and technologies. Quite literally right out of the gate, 3DS surprised us on the bus to the event by announcing that Dassault Systèmes had acquired Medidata Solutions, Inc. for $5.8 billion.